This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Nuclera Ltd. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Christopher Dulson: Innovator in Cell-Free Protein Expression
Introduction: Christopher Dulson is an innovative inventor based in Cambridge, GB. With a notable patent to his name, he has made significant contributions to the field of biotechnology, particularly in protein expression technologies. His groundbreaking work is being further developed at Nuclera Ltd, a company dedicated to advancing scientific research.
Latest Patents: Dulson holds a patent titled "Methods for cell-free protein expression." This invention discloses a method for the cell-free expression of peptides or proteins within a liquid-filled digital microfluidic device. The technology utilizes electrokinesis to manipulate droplets containing the necessary components for protein expression, ultimately enhancing the levels of protein expression within these droplets.
Career Highlights: Throughout his career, Christopher Dulson has focused on merging practical applications of biotechnology with cutting-edge research. His role at Nuclera Ltd has allowed him to collaborate with other leading scientists while targeting innovative solutions in protein synthesis and microfluidic technologies.
Collaborations: Dulson works alongside talented colleagues such as Michael Chun Hao Chen and Sihong Chen. Their collaboration fosters an environment of innovation, as they combine their expertise to push the boundaries of current scientific understanding and applied technologies.
Conclusion: Christopher Dulson's contributions to cell-free protein expression represent a significant step forward in biotechnological advancements. With his patent and collaborative efforts at Nuclera Ltd, he continues to play an essential role in shaping the future of protein synthesis techniques, paving the way for novel applications in various scientific fields.